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Abstract 24
Meniere's disease (MD) is a clinical spectrum of rare disorders characterized by vertigo 25 attacks, associated with sensorineural hearing loss (SNHL) and tinnitus involving low to 26 medium frequencies. Although it shows familial aggregation with incomplete phenotypic 27 forms and variable expressivity, most cases are considered sporadic. The aim of this study 28 was to investigate the burden for rare variation in SNHL genes in patients with sporadic MD. 29
We conducted a targeted-sequencing study including SNHL and familial MD genes in 890 30 MD patients to compare the frequency of rare variants in cases using three independent public 31 datasets as controls. 32
Patients with sporadic MD showed a significant enrichment of missense variants in SNHL 33
genes that was not found in the controls. The list of genes includes GJB2, USH1G, SLC26A4, 34
ESRRB and CLDN14. A rare synonymous variant with unknown significance was found in 35 the MARVELD2 gene in several unrelated patients with MD. 36
There is a burden of rare variation in certain SNHL genes in sporadic MD. Furthermore, the 37 physical interaction of specific gene variants at protein level can explain the additive effect of 38 rare variants in different genes in MD. This study will contribute to design a gene panel for 39 the genetic diagnosis of MD. in familial MD show partial syndromes, either with SNHL or episodic vertigo, increasing the 62 granularity in the phenotype in a given family. However, the genetic contribution of familial 63 genes in sporadic cases has not been investigated and the occurrence of recessive and de novo 64 variation (DNV) is not known. More than 110 genes and ≈ 6000 variants have been related to 65 hereditary non-syndromic hearing loss, making gene sequencing panels an essential tool for 66 genetic diagnosis of hearing loss (Sloan-Heggen et al. 2016 in Table S1 and Table S2 . 105
The custom panel (Panel ID: 39351-1430751809) were designed by the Suredesign 106 webtool (Agilent) to cover the exons and 50 bp in the flanking regions (5' and 3' UTR). This 107 allowed the sequencing around 533.380kb with more than 98.46% coverage. 108 which cannot allow the same approach, but can automatically address high number of calls 135 with a different approach. Variants with read depth (RD) <10 and genotype quality (GQ)<20 136
Sample pooling
were excluded in all the calling pipelines following recommended hard filtering steps by 137 GATK suite. 138 A third caller tool, VarScan, was used to filter and annotate quality strand data per 139 variant to compare its output with GATK-based callers. VarScan allows the variant filtering 140 using the information obtained according to each strand polarity. The method retrieves those 141 variants that were only called in one strand, but not in the reverse strand, leading to false 142 positive calls. This step was used as internal quality control to avoid strand bias usually 143 generated in Haloplex data, as it has been reported in other studies (Collet et al. 2015) . 144
Positive control SNV validation
Positive control testing was addressed using samples from patients with familial MD 145 with known variants on certain genes. These individuals come from previous familial studies 146 with independently validated variants by Sanger sequencing. Known variants were also 147 sequenced and validated by Sanger (Table S3 ). Coverage and mapping quality after each 148 pipeline were annotated and measured. Representative chromatographs from validated SNVs 149 are detailed in Figure S1 . 150
Selection and prioritization of pathogenic SNV
In order to obtain more information of each SNV, we annotated the merged files using 151 the ANNOVAR tool. synonymous, 1 stoploss, 1 stopgain). All the exonic variants were annotated and scored using 196 different priorization tools. Of them, 136 SNVs were not previously described in any 197 population database and we considered them as possible de novo variants (DNVs). 198
After prioritizing the exonic variants, 31 rare variants remained ( Table 2) . Six of them 199
were validated by Sanger sequencing in more than 2 individuals in the following genes: 200 GJB2, ESRRB, USH1G, SLC26A4 (Table S3 ). The rest of the variants were considered benign 201 or likely benign since they did not reach the pathogenicity threshold predicted for KGGSeq. 202
However, a novel synonymous variant in the MARVELD2 gene was found and validated in 3 203 unrelated individuals. 204
The minor allelic frequencies in SNV of the 24 mitochondrial genes included in the 205 panel were compared with the reference data obtained from MITOmap through its automated 206 mtDNA sequence analysis system Mitomaster (Ruiz-Pesini et al. 2007 ). However, we did not 207
found any SNV associated with MD (data not shown). 208
Gene burden analysis 209
To analyse the interaction of multiple variants, we considered SNV with a MAF<0.1 210 for the gene burden analysis. A total of 957 exonic variants were retrieved and their 211 frequencies were compared with the global and NFE frequencies from ExAC, and with the 212 Spanish population frequencies from CSVS. 213
A gene burden analysis using our gene set was performed using these three reference 214
datasets. After Bonferroni correction, some genes showed a significant enrichment of rare 215 variants in the three comparisons, making them candidate genes to be selected for a diagnosis 216 panel for MD (Table 3) . Moreover, 6 genes (FAM136A, ADD1, SLC12A2, POU4F3, RDX 217
and PRKCB) presented some novel variants that were validated by Sanger, but they have not 218 been described in global ExAC or CSVS datasets. Although these variants could not be 219 sequenced in all the parents of these patients, we considered them as DNV. 220
A second variant analysis using the missense variants described in CSVS Spanish 221 population database was made (Table 4 ). Eighteen genes showed an excess of missense 222 variants (a total of 46 variants, detailed in Table S4 ). Of note, five genes causing autosomal 223 recessive SNHL showed the highest accumulation of missense variants when they were 224 compared with NFE and Spanish population datasets: SLC26A4, GJB2, CLDN14, ESRRB and 225
USH1G. The variants in these five genes were validated through Sanger sequencing and 226
considered Spanish population-specific variants. 227
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Excess of rare variants in hearing loss genes in familial cases 228
We used exome sequencing datasets from familial MD cases previously reported to 229 search for rare variants identified in our panel in the sporadic cases. Although no single 230 missense variant was found segregated in all the cases in the same family, we found several 231 rare missense variants in at least one case per family in genes such as GJB2, GRHL2, 232 TRIOBP, RDX, KCNQ4, WFS1 and ADD1. These MD families show phenotypic differences 233
in terms of age of onset, hearing profile and disease progression and the presence of rare 234 variants can be addressed as potential modulators of the phenotype in each familial case 235 (Table 5) . 236
Effect of rare variant interaction 237
We selected exonic variants from the gene burden analysis to analyze their potential 238 additive effect at protein-protein interaction interfaces by the tool INSIDER for our selected 239 five genes. However, protein interfaces for ESRRB, CLDN14 and SLC26A4 genes could not 240 be loaded and processed on the database (lacking predicted interfaces on ÉCLAIR database or 241 crystalized protein structures on Protein Data Bank (PDB) database). Of note, most relevant 242 affected interaction is observed in the self-interaction GJB2-GJB2 by the known variants 243 observed in the burden analysis (significant spatial clustering with 4 SNV, p=0.0009) 244
rs111033218:G>C, rs80338945:A>G, rs374625633:T>C and rs2274084:C>T ( Fig 1A) . 245
Other interactions of interest were founded between the USH1G -USH1C genes, but 246 the involved variants were not located in the known interaction surface of USH1G ( Fig 1B) . 247
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Discussion 248 This study shows that patients with sporadic MD have an enrichment of few rare 249 variants in certain hearing loss genes such as GJB2, SLC26A or USH1G. This excess of 250 missense variants in some genes may increase the risk to develop hearing loss in MD and may 251 contribute to explain the heterogeneity observed in the phenotype (Francioli et al. 2015) . To 252 understand the relevance of population frequencies in our cohort, we performed the 253 association analysis between variants observed in MD cases against their respective 254 frequencies on a healthy population for each gene of the panel. From the total amount of 255 variants, we selected exonic variants for all the targeted genes. We applied a stronger filter for 256 the selection of missense variants by choosing previously described variants for each gene 257 significantly overrepresented in MD cases. 258
Since many missense variants were not found in the Spanish population from CSVS, a 259 third comparison limited to those variants described in CSVS database was carried out. We 260 followed this conservative approach to reduce false positive findings in the readings. This 261 third restrictive gene analysis was limited to 132 variants observed at least once in the 262
Spanish reference population. 263
From the final analysis, we found that some genes such as SLC26A4, ESRRB, 264
CLDN14, GJB2 and USH1G retained the higher number of missense variants among Spanish 265 MD patients. We also found one synonymous variant in the MARVELD2 gene. Besides from 266
its functional implications, it may also generate a cryptic splice site. However, more testing is 267 needed to confirm this hypothesis. 268
Gene panel for familial MD 269
The Genomics England project (https://www.genomicsengland.co.uk/) has designed gene 270 panels for the diagnosis of many genetic disorders including familial MD 271 (https://panelapp.genomicsengland.co.uk/panels/394/). This panel is in an early stage of 272 development because it only considers 130 genes with limited evidence to few families. The 273
results of this study can be used to improve the design of panels for the diagnosis of MD. 274
For the design of our panel, we chose a total of 69 genes. Most of the genes were selected 275 according to the hearing loss profile (low frequency or pantonal hearing loss and to decrease this granularity in the phenotype, it will be recommendable to select sporadic 288 patients with an early age of onset for future studies. 289
Rare variants in hearing loss genes in sporadic MD
The frequency of hearing loss related genes is population-specific (Sloan-Heggen et al. 290 2016). Herein, we present a study for MD patients in the Spanish population. As a part of the 291 study, we consider a panel of genes related to hearing loss and other symptoms. Besides from 292 the validated variants in singletons, only a few rare variants such as ESRRB 293 rs201448899:C>T, MARVELD2 rs369265136:G>A, SLC26A4 rs200511789:A>C and 294
USH1G rs151242039:C>T have been validated in more than one sporadic case in the entire 295 cohort. All these genes had been previously considered as pathogenic for hearing loss, but 296 they have never been involved with MD. 297 with other known largest frequencies as NFE, suggests that this is a population specific 319 variant rather than a MD disease variant. Only the MARVELD2 rs369265136:G>A variant 320 remains as a proper DNV related to MD cases. However, the functional effect of a 321 synonymous variant is unknown and functional studies will be required to decipher the 322 relevancy of this variant in MD cases in the future. 323
Burden analysis of rare missense variants in sporadic MD
Our results demonstrate a burden of rare missense variants in few SNHL genes, including 324 GJB2, ESRRB, CLDN14, SLC26A4 and USH1G. We speculate that the additive effect of 325 several missense variants in the same gene could interact with the same or other genes at the 326 protein level resulting in the hearing loss phenotype. 327
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Population analysis was addressed in order to obtain a better image of our cohort. Despite 328 the limitation that represents the small number of genes considered in our panel, we have 329 found a significant increase of missense variants on several hearing loss genes in the Iberian 330 population (Table 4 ). These findings suggest the involvement of multiple missense variants in 331 the same gene and may explain several clinical findings in MD. So, incomplete phenotype 332 found in relatives of patients with familial MD or even the variable expressivity observed 333 could be explained on the differences found in multiple rare variants with additive effect 334 among individuals of the same family (Requena et al. 2015; Martín-Sierra et al. 2016 , 2017 . 335
In addition, some sporadic cases where a single rare variant with unknown significance 336 cannot explain the phenotype could be singletons individuals with several low frequency 337 variants probably following a compound heterozygous recessive pattern of inheritance. Our 338 results start to decipher the complex interaction between rare and ultrarare variations (MAF< 339 0.0001) in the same or different genes in sporadic MD, adding more evidence to understand 340 the genetic architecture of MD. 341
First, the phenotype of MD could be the result of additive effect of low frequency or rare 342 variants in the same gene. A good number of common or low frequency variants in the same 343 gene can be a rare situation, as rare as the disease. domain, this could be of interest when considering interaction between different proteins as a 362 main factor to develop a mild phenotype. This hypothesis was reinforced through the data 363 found in familial cases. For instance, the variant rs748718975 in DPT gene was only 364 associated with the SNHL phenotype in the family where it was described, but these cases 365 showed different characteristics in the age of onset or hearing loss outcome. These differences 366 between the cases can be explained with other variants found in KCNQ4 (rs574794136:G>A) 367
and ADD1 (rs372777117:A>G) genes, although these variants were previously described as 368 variants of unknown significant. So, the variant rs574794136:G>A was found in two sisters 369 with MD, but not in the third one, that was carrier of rs372777117:A>G. This excess of rare 370 variants in certain genes observed in familial cases could explain the differences in 371 expressivity in a given family. 372
This panel was made as an early screening diagnostic panel. Here we have found that 373 certain SNHL gene variants can be related to MD in the Iberian population and the results 374 I n r e v i e w show that multiple rare allelic variants in the same gene should be consider as likely 375 pathogenic. Our results will contribute to design a better gene panel for the genetic diagnosis 376 of MD. 377 
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